<?xml version="1.0" encoding="UTF-8"?>
<ref id="B84">
 <label>84</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chong</surname>
    <given-names>W. C.</given-names>
   </name>
   <name>
    <surname>Gundamaraju</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Vemuri</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Scotti</surname>
    <given-names>M. T.</given-names>
   </name>
   <name>
    <surname>Scotti</surname>
    <given-names>L.</given-names>
   </name>
  </person-group>
  <article-title>Momordicacharantia: a new strategic vision to improve the therapy of endoplasmic reticulum stress</article-title>
  <source>
   <italic toggle="yes">Current Pharmaceutical Design</italic>
  </source>
  <year>2017</year>
  <volume>23</volume>
  <issue>16</issue>
  <fpage>2333</fpage>
  <lpage>2343</lpage>
  <pub-id pub-id-type="doi">10.2174/1381612823666170124141104</pub-id>
  <pub-id pub-id-type="other">2-s2.0-85017201486</pub-id>
  <pub-id pub-id-type="pmid">28120728</pub-id>
 </element-citation>
</ref>
